Home/Abera Bioscience/Mats Lundgren
ML

Mats Lundgren

CSO

Abera Bioscience

Therapeutic Areas

Abera Bioscience Pipeline

DrugIndicationPhase
Nasal Pneumococcal VaccinePneumococcal disease (serotype-independent)Pre-clinical
Nasal Influenza VaccineInfluenzaPre-clinical